Adding Bempedoic Acid to Standard Care After a Heart Attack
Part of Heart & circulation clinical trials.
This study tests adding a newer cholesterol-lowering pill (bempedoic acid) to usual care for people who have been recently hospitalized for a heart event. It aims to see if the combination helps lower cholesterol better than standard medicines alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were hospitalized for a heart attack or unstable angina and have LDL cholesterol between 70 and 140 mg/dL.
- You are not already taking the strongest cholesterol drug combination (high dose statin plus ezetimibe) when you came in.
- You are not currently on, or planning to take, newer injectable cholesterol drugs (PCSK9 inhibitors or inclisiran).
- You do not have severe kidney or liver disease, very high triglycerides, or a genetic high cholesterol condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting strong cholesterol-lowering treatment early in the hospital can improve outcomes for people with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina). It may help if you have high LDL cholesterol.
This study tests if a team of specialists working together can help people who have had a heart attack lower their bad cholesterol (LDL) more effectively than standard care. It aims to improve long-term heart health.
This study is checking how well people stick with taking bempedoic acid, a cholesterol-lowering medication, and how effective it is over time.
This trial tests whether bempedoic acid, a cholesterol-lowering drug, improves outcomes and reduces inflammation in people who have had a severe heart attack treated with emergency angioplasty.
This trial tests a new medicine called bempedoic acid compared to statins for people who have trouble sticking with statins. It looks at how well each medicine lowers 'bad' cholesterol and how well they are tolerated.
This trial tests a triple therapy pill (bempedoic acid, ezetimibe, and a high-intensity statin) in patients who have extensive plaque in their heart arteries but have never had a heart attack or stroke. It aims to see if this combination can further lower cholesterol and prevent future problems.
Hear when a new Secondary Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.